Skip to main content

Table 2 Changes in lipid profile during treatment according to treatment group1(paired sample t teatst)

From: Influence of intense multidisciplinary follow-up and orlistat on weight reduction in a primary care setting

  Group A Group B Group C
Number of patients2 32 55 28
Initial triglycerides (mg/dl, +/- SD) 170 ± 53 184 ± 49 255 ± 205
Final triglycerides (mg/dl, +/- SD) 139 ± 43 153 ± 35 165 ± 60
Delta (+/- SD) -31 ± 21 -31 ± 25 -90 ± 187
P value (pre-post) <0.001 <0.001 0.01
Initial low density lipids (LDL; mg/dl, +/- SD) 150 ± 30 156 ± 36 152 ± 44
Final LDL (mg/dl, +/- SD) 129 ± 28 143 ± 32 147 ± 34
Delta -21 ± 26 -12 ± 16 -5 ± 34
P value (pre-post) <0.001 <0.001 NS
Initial high density lipids (HDL; mg/dl, +/- SD) 42 ± 7.0 44 ± 6.7 47 ± 14.9
Final HDL (mg/dl, +/- SD) 43 ± 6.6 45 ± 6.7 48 ± 15.3
Delta (+/- SD) 0.9 ± 2.9 0.8 ± 3.3 1.4 ± 8.8
P value (pre-post) NS NS NS
  1. NS = Not significant.
  2. 1 See footnotes to Table 1
  3. 2 Patients with pre and post lipid profile analyses